Login
- Title:
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL – Results From the Phase-II STORM Trial
- Document type:
- Zeitschriftenaufsatz
- Author(s):
- Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meißner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosée, Paul; Buske, Christian; Dreyling, Martin H.; Hess, Georg
- Journal title:
- HemaSphere
- Year:
- 2021
- Journal volume:
- 5
- Journal issue:
- 10
- Pages contribution:
- e636
- Fulltext / DOI:
- doi:10.1097/hs9.0000000000000636
- Publisher:
- Ovid Technologies (Wolters Kluwer Health)
- E-ISSN:
- 2572-9241
- Date of publication:
- 23.09.2021
BibTeX
Occurrences: